Effect of indomethacin on E-cadherin and beta-catenin expression in HT-29 colon cancer cells
- PMID: 15963497
- DOI: 10.1016/j.yexmp.2005.04.008
Effect of indomethacin on E-cadherin and beta-catenin expression in HT-29 colon cancer cells
Abstract
Nonsteroidal anti-inflammatory drugs (NSAIDs) lower the incidence of and mortality from colon cancer. Although there is much evidence from epidemiological and laboratory studies that NSAIDs have antitumor activity and reduce the incidence of colon cancer, the mechanism of action remains unknown. In this paper, we present the effect of indomethacin on growth inhibition, induction of apoptosis, and alterations in the expression of several genes involved in Wnt signaling in HT-29 colon cancer cells. We have shown that indomethacin reduces the proliferation rate of HT-29 colon cancer cells and induces apoptosis. Concentrations of indomethacin from 10(-4) to 10(-3) M strongly inhibited the growth of HT-29 cells. The inhibition of growth, as well as induction of apoptosis was dose and time dependent. The treatment of cells with 4 x 10(-4) M indomethacin caused strong inhibition of cell growth (about 70%), enhanced expression of APC, decreased expression of beta-catenin and induced expression of E-cadherin proteins. Expression of beta-catenin was not markedly reduced instead, beta-catenin was translocated from the nucleus and cytoplasm to the plasma membrane. These results were confirmed by real-time RT-PCR analysis on mRNA level. At a concentration of 4 x 10(-4) M indomethacin there was increased expression of APC gene (10.9-fold induction; DeltaDeltaCt = 3.43) and E-cadherin gene (3.5-fold induction; DeltaDeltaCt = 1.79). These results suggest the antiproliferative effect of indomethacin may contribute to enhanced cell adhesion through increased expression of E-cadherin and translocation of beta-catenin from the nucleus to the cell membrane.
Similar articles
-
Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.Cancer Invest. 2009 Jul;27(6):604-12. doi: 10.1080/07357900802337191. Cancer Invest. 2009. PMID: 19440933
-
[Effects of hFRNK on E-cadherin/beta-catenin in colon cancer cells in vitro].Zhonghua Zhong Liu Za Zhi. 2007 May;29(5):346-50. Zhonghua Zhong Liu Za Zhi. 2007. PMID: 17892129 Chinese.
-
Celecoxib inhibits the expression of survivin via the suppression of promoter activity in human colon cancer cells.Biochem Pharmacol. 2007 May 1;73(9):1318-29. doi: 10.1016/j.bcp.2006.12.033. Epub 2007 Jan 5. Biochem Pharmacol. 2007. PMID: 17270149
-
Vitamin D and Wnt/beta-catenin pathway in colon cancer: role and regulation of DICKKOPF genes.Anticancer Res. 2008 Sep-Oct;28(5A):2613-23. Anticancer Res. 2008. PMID: 19035286 Review.
-
beta-Catenin signaling in biological control and cancer.J Cell Biochem. 2007 Nov 1;102(4):820-8. doi: 10.1002/jcb.21505. J Cell Biochem. 2007. PMID: 17854061 Review.
Cited by
-
[E-cadherin/beta-catenin and the invasion and metastasis of lung cancer].Zhongguo Fei Ai Za Zhi. 2010 Mar;13(3):254-9. doi: 10.3779/j.issn.1009-3419.2010.03.11. Zhongguo Fei Ai Za Zhi. 2010. PMID: 20673524 Free PMC article. Review. Chinese. No abstract available.
-
PRIMA-1MET induces apoptosis through accumulation of intracellular reactive oxygen species irrespective of p53 status and chemo-sensitivity in epithelial ovarian cancer cells.Oncol Rep. 2016 May;35(5):2543-52. doi: 10.3892/or.2016.4653. Epub 2016 Mar 3. Oncol Rep. 2016. PMID: 26986846 Free PMC article.
-
Heterogeneous gene expression changes in colorectal cancer cells share the WNT pathway in response to growth suppression by APHS-mediated COX-2 inhibition.Biologics. 2008 Jun;2(2):329-37. doi: 10.2147/btt.s2663. Biologics. 2008. PMID: 19707365 Free PMC article.
-
Indometacin ameliorates high glucose-induced proliferation and invasion via modulation of e-cadherin in pancreatic cancer cells.Curr Med Chem. 2013;20(33):4142-4152. doi: 10.2174/09298673113209990249. Curr Med Chem. 2013. PMID: 23992308 Free PMC article.
-
Chemotherapy and Physical Therapeutics Modulate Antigens on Cancer Cells.Front Immunol. 2022 Jul 6;13:889950. doi: 10.3389/fimmu.2022.889950. eCollection 2022. Front Immunol. 2022. PMID: 35874714 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials